a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with XNCR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then XNCR could also see price increases.
Ticker / NAME | Correlation To ATNM | 1D Price Change % | ||
---|---|---|---|---|
ATNM | 100% | -6.03% | ||
XNCR - ATNM | 40% Loosely correlated | -3.14% | ||
GBIO - ATNM | 38% Loosely correlated | -7.58% | ||
NTLA - ATNM | 37% Loosely correlated | -3.65% | ||
TRVI - ATNM | 37% Loosely correlated | -6.01% | ||
GMAB - ATNM | 36% Loosely correlated | -1.40% | ||
More |
Ticker / NAME | Correlation To ATNM | 1D Price Change % |
---|---|---|
ATNM | 100% | -6.03% |
cancer theme (87 stocks) | 42% Loosely correlated | +0.89% |
drugs theme (265 stocks) | 41% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 40% Loosely correlated | +5.56% |
immunotherapy theme (13 stocks) | 34% Loosely correlated | -0.95% |
biopharmaceuticals theme (52 stocks) | 34% Loosely correlated | +2.00% |